A$ 25.43
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Solid dividends
About
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health...
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EB
Target Price
The average target price of EBO.AX is 34 and suggests 39% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
